CANCER TREATMENT PATHWAYS AND GUIDELINES

AIM CANCER TREATMENT PATHWAYS

AIM Cancer Treatment Pathways are cancer treatment regimens intended to support quality cancer care and reduce unneeded variation in care and cost. They are developed through a rigorous process of integrating evidence-based literature with physician practice guidelines.

OPEN THE CANCER TREATMENT PATHWAYS

AIM CLINICAL APPROPRIATENESS GUIDELINES
FOR FEBRILE NEUTROPENIA RISK

The AIM Clinical Appropriateness Guidelines for Febrile Neutropenia Risk address determination of febrile neutropenia risk to guide the use of white blood cell growth factors for oncology drug treatment regimens in adults.

OPEN THE GUIDELINES FOR FEBRILE NEUTROPENIA RISK

 

About the members of the AIM Medical Oncology Cancer Treatment Pathways Advisory Panel

The external oncologists on the AIM Medical Oncology Cancer Treatment Pathways Advisory Panel help develop and update our pathways. To learn more about the oncologists’ affiliations, view a summary of their financial conflict of interest declarations.

LEARN MORE

Trouble viewing the pathways or guidelines?

To open our pathways or guidelines, your computer needs Adobe Reader, free and trusted software that allows you to view PDFs.

GET ADOBE READER